Increasing the Duration of Light Physical Activity Ameliorates Insulin Resistance Syndrome in Metabolically Healthy Obese Adults.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
11 05 2020
Historique:
received: 03 04 2020
revised: 28 04 2020
accepted: 06 05 2020
entrez: 15 5 2020
pubmed: 15 5 2020
medline: 25 2 2021
Statut: epublish

Résumé

Obesity is a well-known risk factor for insulin resistance syndrome (IRS). Nevertheless, limited data are available regarding the effects of physical activity (PA) intensity on the ability to modulate IRS. The study aim was to investigate the beneficial effects of the longer duration of light PA vs. a single bout of the acute moderate or vigorous PA for improvement in IRS indicators. Sixty metabolically healthy obese (MHO) participants, 30 males and 30 females, with body mass index (BMI) of ≥30 were enrolled in this study. PA levels were measured using an accelerometer, and the expression of monocytic surface markers was analyzed using flow cytometry. Plasma cytokines' secretion was determined by enzyme-linked immunosorbent assay (ELISA). Univariate regression analysis evaluated the actigraphy-assessed PA measures, inflammatory cytokines, and insulin resistance. The longer duration of PA was found to be associated with the homeostatic model assessment of insulin resistance (HOMA-IR), a lower lipid profile, and the expression of inflammatory cytokines by monocytes. Even though, higher intensities of PA were found to be associated with lower body fat percentage, only the light intensity PA was found to be beneficial as it associated with the improved insulin sensitivity and lower expression of inflammatory markers. In conclusion, maintaining the longer duration of low-intensity PA throughout the day could be more beneficial for reducing inflammation and improving insulin resistance. This study supports a more feasible approach model to gain beneficial lifestyle changes for the prevention of IRS in metabolically healthy adults with obesity.

Identifiants

pubmed: 32403230
pii: cells9051189
doi: 10.3390/cells9051189
pmc: PMC7290973
pii:
doi:

Substances chimiques

Antigens, CD 0
Biomarkers 0
Cytokines 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Sports Med (Hindawi Publ Corp). 2016;2016:7186137
pubmed: 27239554
J Exerc Rehabil. 2017 Aug 29;13(4):472-476
pubmed: 29114515
Int J Obes (Lond). 2015 Mar;39(3):514-9
pubmed: 25287753
BMB Rep. 2019 Jun;52(6):360-372
pubmed: 31186085
Diabetes Care. 2002 Jul;25(7):1177-84
pubmed: 12087016
Diabetologia. 2016 May;59(5):879-94
pubmed: 26940592
Fertil Steril. 2017 Apr;107(4):833-839
pubmed: 28292617
Obesity (Silver Spring). 2016 Jan;24(1):102-12
pubmed: 26576827
J Orthop Sports Phys Ther. 2018 Jun;48(6):439-447
pubmed: 29669488
J Am Coll Cardiol. 2014 Dec 2;64(21):2281-93
pubmed: 25456761
Br J Radiol. 2012 Jan;85(1009):1-10
pubmed: 21937614
Diabetes Metab Syndr Obes. 2019 Apr 26;12:565-573
pubmed: 31118719
J Am Heart Assoc. 2012 Dec;1(6):e003152
pubmed: 23316320
Physiol Rep. 2017 Jul;5(13):
pubmed: 28684638
Front Endocrinol (Lausanne). 2019 Jul 09;10:449
pubmed: 31338067
PLoS One. 2015 Mar 17;10(3):e0121971
pubmed: 25781614
Curr Opin Pharmacol. 2017 Dec;37:35-40
pubmed: 28843953
Appl Physiol Nutr Metab. 2016 Jun;41(6 Suppl 3):S311-27
pubmed: 27306437
Obes Rev. 2015 Feb;16(2):127-36
pubmed: 25586506
Brain Behav Immun. 2019 Aug;80:818-824
pubmed: 31125712
J Leukoc Biol. 2008 Nov;84(5):1271-8
pubmed: 18664531
Med Sci Sports Exerc. 1998 Jun;30(6):899-905
pubmed: 9624649
Eur J Clin Invest. 2017 Aug;47(8):600-611
pubmed: 28722106
J Clin Endocrinol Metab. 2007 Jun;92(6):2041-5
pubmed: 17389699
Am J Clin Nutr. 2016 Nov;104(5):1424-1432
pubmed: 27707702
Eur J Epidemiol. 2011 Aug;26(8):647-55
pubmed: 21681546
Obes Surg. 2002 Jun;12(3):335-42
pubmed: 12082883
Obesity (Silver Spring). 2013 Jan;21(1):32-44
pubmed: 23505166
Appl Physiol Nutr Metab. 2017 Jul;42(7):725-731
pubmed: 28199795
Mol Cell Endocrinol. 2010 Jan 15;314(1):1-16
pubmed: 19682539
J Appl Physiol (1985). 2008 Sep;105(3):977-87
pubmed: 18635884
Am J Clin Nutr. 2005 Jul;82(1 Suppl):226S-229S
pubmed: 16002826
Int J Environ Res Public Health. 2019 Oct 21;16(20):
pubmed: 31640279
J Immunol. 2015 Apr 15;194(8):3917-23
pubmed: 25786686
Lancet Glob Health. 2016 Oct;4(10):e704-13
pubmed: 27568068
J Sports Sci. 2018 Jan;36(2):149-155
pubmed: 28282751
Int J Obes (Lond). 2014 Aug;38(8):1089-96
pubmed: 24285336
Med Sci Sports Exerc. 1998 May;30(5):777-81
pubmed: 9588623
Diabetes. 1985 Oct;34(10):973-9
pubmed: 3930321
Eur Heart J. 2010 Feb;31(3):369-76
pubmed: 19687164
Am J Cardiol. 1990 Apr 15;65(15):1010-3
pubmed: 2327335
ISRN Inflamm. 2013 Dec 22;2013:139239
pubmed: 24455420
Circulation. 2011 Aug 16;124(7):789-95
pubmed: 21810663
J Am Coll Surg. 2008 Dec;207(6):928-34
pubmed: 19183541
J Leukoc Biol. 2007 Mar;81(3):584-92
pubmed: 17135573
Cell Biochem Funct. 2016 Jun;34(4):209-16
pubmed: 27027694
Exerc Immunol Rev. 2003;9:48-57
pubmed: 14686094
Med Sci Sports Exerc. 2009 Apr;41(4):818-27
pubmed: 19276851
Int J Sports Med. 2013 Jan;34(1):62-7
pubmed: 22903316
Hypertension. 2010 Sep;56(3):540-6
pubmed: 20606102
Ann Glob Health. 2019 Mar 21;85(1):
pubmed: 30924616
Health Educ Res. 1999 Dec;14(6):803-15
pubmed: 10585387
Eur J Appl Physiol. 2020 Jan;120(1):127-135
pubmed: 31707476
Exerc Immunol Rev. 2002;8:6-48
pubmed: 12690937
Med Sci Sports Exerc. 2016 Jul;48(7):1303-11
pubmed: 26848889

Auteurs

Fatema Al-Rashed (F)

Immunology & Microbiology Department, Dasman Diabetes Institute, Kuwait 15462, Kuwait.
Kuwait Ministry of Health, Mubarak Al-Kabeer Hospital, Immunology Department, Kuwait 13001, Kuwait.

Abdulwahab Alghaith (A)

Royal College of Surgeons in Ireland (RCSI), D02 YN77 Dublin, Ireland.

Rafaat Azim (R)

Immunology & Microbiology Department, Dasman Diabetes Institute, Kuwait 15462, Kuwait.

Dawood AlMekhled (D)

Immunology & Microbiology Department, Dasman Diabetes Institute, Kuwait 15462, Kuwait.

Reeby Thomas (R)

Immunology & Microbiology Department, Dasman Diabetes Institute, Kuwait 15462, Kuwait.

Sardar Sindhu (S)

Animal and Imaging Core Facility, Dasman Diabetes Institute, Kuwait 15462, Kuwait.

Rasheed Ahmad (R)

Immunology & Microbiology Department, Dasman Diabetes Institute, Kuwait 15462, Kuwait.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH